Ribo-lite (Low-input Ribo-seq)
Immuno Ribo-seq
Selective Ribo-seq
Active mRNA Sequencing (Active mRNA-seq)
Active Ribo-seq
Poly(A)-tail-associated Ribosome Profiling (Poly-seq)
Provides integrated solutions for the entire process from sample preparation, deep sequencing to data analysis, creating end-to-end closed-loop services for gene research. Whole genome sequencing | early cancer screening | genetic disease screening | individualized medication guidance. AI-driven diagnosis and treatment plans empower scientific research transformation and clinical decision-making, allowing precision medicine to run through the entire cycle of "prevention-diagnosis-treatment-rehabilitation".
RiboNext (Ningbo) Biotechnology Co., Ltd. (referred to as "RiboNext Bio") is an innovation-driven company focused on the frontier of precision medicine. Guided by its mission to "decode life dynamics and empower precision healthcare," the company leverages a globally advanced translatomics technology platform and high-resolution structural biology techniques. By integrating multi-dimensional data from transcriptomics and translatomics, RiboNext is dedicated to uncovering the molecular mechanisms underlying disease progression and providing a scientific foundation for clinical diagnostics, drug development, and personalized therapies.
With the core philosophy of "multi-omics convergence and cross-scale analysis," RiboNext aims to become the global leader in decoding the "translation code" within precision medicine, driving a paradigm shift in life sciences — from understanding gene sequences to realizing biological function — and delivering transformative solutions for human health.